Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution

Bahar Rastegar, Natalie Andersson, Alexandra Petersson, Jenny Karlsson, Subhayan Chattopadhyay, Anders Valind, Caroline Jansson, Geoffroy Durand, Patrik Romerius, Karin Jirström, Linda Holmquist Mengelbier, David Gisselsson

Clin Cancer Res (2023) 29 (14): 2668–2677.

https://doi.org/10.1158/1078-0432.CCR-23-0311

Published: 14 July 2023

View article titled, Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution

Includes: Supplementary data

Journal Articles

BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer

Clin Cancer Res (2019) 25 (23): 7139–7150.

https://doi.org/10.1158/1078-0432.CCR-19-0713

Published: 02 December 2019

View article titled, BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer

Includes: Supplementary data

Journal Articles

A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk

Troy Bremer, Pat W. Whitworth, Rakesh Patel, Jess Savala, Todd Barry, Stephen Lyle, Glen Leesman, Steven P. Linke, Karin Jirström, Wenjing Zhou, Rose-Marie Amini, Fredrik Wärnberg

Clin Cancer Res (2018) 24 (23): 5895–5901.

https://doi.org/10.1158/1078-0432.CCR-18-0842

Published: 03 December 2018

View article titled, A Biological Signature for Breast Ductal Carcinoma <em>In Situ</em> to Predict Radiotherapy Benefit and Assess Recurrence Risk

Includes: Supplementary data

Journal Articles

High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy–Treated Patients—Results from a Population-Based Breast Cancer Cohort

Karin Elebro, Signe Borgquist, Ann H. Rosendahl, Andrea Markkula, Maria Simonsson, Karin Jirström, Carsten Rose, Christian Ingvar, Helena Jernström

Clin Cancer Res (2017) 23 (3): 766–777.

https://doi.org/10.1158/1078-0432.CCR-16-1095

Published: 31 January 2017

View article titled, High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy–Treated Patients—Results from a Population-Based Breast Cancer Cohort

Journal Articles

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

Clin Cancer Res (2016) 22 (18): 4664–4675.

https://doi.org/10.1158/1078-0432.CCR-16-0316

Published: 15 September 2016

View article titled, A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

Includes: Supplementary data

Journal Articles

Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort

Karin Elebro, Signe Borgquist, Maria Simonsson, Andrea Markkula, Karin Jirström, Christian Ingvar, Carsten Rose, Helena Jernström

Clin Cancer Res (2015) 21 (16): 3640–3650.

https://doi.org/10.1158/1078-0432.CCR-14-2564

Published: 13 August 2015

View article titled, Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort

Includes: Supplementary data

Journal Articles

Abstract A37: Ectopic claudin 6 and 18.2 expression as potential treatment target in non-small cell lung cancer.

Johanna SM Mattsson, Patrick Micke, Karolina Edlund, Miriam Lohr, Karin Jirström, Anders Berglund, Johan Botling, Jörg Rahnenfuehrer, Millaray Marincevic, Fredrik Pontén, Simon Ekman, Jan G. Hengstler, Stefan Wöll, Ugur Sahin, Özlem Türeci

Clin Cancer Res (2014) 20 (2_Supplement): A37.

https://doi.org/10.1158/1078-0432.14AACRIASLC-A37

Published: 16 January 2014

View article titled, Abstract A37: Ectopic claudin 6 and 18.2 expression as potential treatment target in non-small cell lung cancer.

Journal Articles

G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients

Stefan Broselid, Benxu Cheng, Martin Sjöström, Kristina Lövgren, Heather L.P. Klug-De Santiago, Mattias Belting, Karin Jirström, Per Malmström, Björn Olde, Pär-Ola Bendahl, Linda Hartman, Mårten Fernö, L.M. Fredrik Leeb-Lundberg

Clin Cancer Res (2013) 19 (7): 1681–1692.

https://doi.org/10.1158/1078-0432.CCR-12-2376

Published: 02 April 2013

View article titled, G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients

Includes: Supplementary data

Journal Articles

Abstract A9: The cocaine and amphetamine-regulated transcript (CART) is an independent prognostic factor in lymph node-negative breast cancer and predicts outcome in tamoxifen treated patients

Darran O'Connor, Donal Brennan, Henriette Laursen, Rene Bernards, John Crown, Karin Jirstrom, William Gallagher

Clin Cancer Res (2012) 18 (10_Supplement): A9.

https://doi.org/10.1158/1078-0432.MECHRES-A9

Published: 04 March 2013

View article titled, Abstract A9: The cocaine and amphetamine-regulated transcript (CART) is an independent prognostic factor in lymph node-negative breast cancer and predicts outcome in tamoxifen treated patients

Journal Articles

Abstract A10: Peroxiredoxin-1 and oxidative stress: Controlling the balance between oncogenic and endocrine signalling in estrogen receptor-positive breast cancer

Patrick C. O'Leary, Donal J. Brennan, John Crown, William M. Gallagher, Radoslaw Zagozdzon, Yue Fan, Bryan T. Hennessy, Ana-Maria Gonzalez-Angulo, Gordon Mills, Fredrik Ponten, Karin Jirstrom, Mathias Uhlen, Darran O'Connor

Clin Cancer Res (2012) 18 (10_Supplement): A10.

https://doi.org/10.1158/1078-0432.MECHRES-A10

Published: 04 March 2013

View article titled, Abstract A10: Peroxiredoxin-1 and oxidative stress: Controlling the balance between oncogenic and endocrine signalling in estrogen receptor-positive breast cancer

Journal Articles

miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

Laoighse Mulrane, Stephen F. Madden, Donal J. Brennan, Gabriela Gremel, Sharon F. McGee, Sara McNally, Finian Martin, John P. Crown, Karin Jirström, Desmond G. Higgins, William M. Gallagher, Darran P. O'Connor

Clin Cancer Res (2012) 18 (24): 6702–6713.

https://doi.org/10.1158/1078-0432.CCR-12-1420

Published: 16 December 2012

View article titled, miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential <em>In Vitro</em>

Includes: Supplementary data

Journal Articles

Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

Clin Cancer Res (2012) 18 (15): 4026–4036.

https://doi.org/10.1158/1078-0432.CCR-12-0343

Published: 30 July 2012

View article titled, Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

Includes: Supplementary data

Journal Articles

Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

Jermaine Coward, Hagen Kulbe, Probir Chakravarty, David Leader, Vessela Vassileva, D. Andrew Leinster, Richard Thompson, Tiziana Schioppa, Jeffery Nemeth, Jessica Vermeulen, Naveena Singh, Norbert Avril, Jeff Cummings, Elton Rexhepaj, Karin Jirström, William M. Gallagher, Donal J. Brennan, Iain A. McNeish, Frances R. Balkwill

Clin Cancer Res (2011) 17 (18): 6083–6096.

https://doi.org/10.1158/1078-0432.CCR-11-0945

Published: 14 September 2011

View article titled, Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

Includes: Supplementary data

Journal Articles

Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer

Anna-Maria Larsson, Karin Jirström, Erik Fredlund, Sofie Nilsson, Lisa Rydén, Göran Landberg, Sven Påhlman

Clin Cancer Res (2009) 15 (17): 5552–5559.

https://doi.org/10.1158/1078-0432.CCR-08-3014

Published: 31 August 2009

View article titled, Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer

Includes: Supplementary data

Journal Articles

Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer

Donal J. Brennan, Elton Rexhepaj, Sallyann L. O'Brien, Elaine McSherry, Darran P. O'Connor, Ailís Fagan, Aedín C. Culhane, Desmond G. Higgins, Karin Jirstrom, Robert C. Millikan, Goran Landberg, Michael J. Duffy, Stephen M. Hewitt, William M. Gallagher

Clin Cancer Res (2008) 14 (9): 2681–2689.

https://doi.org/10.1158/1078-0432.CCR-07-1760

Published: 01 May 2008

View article titled, Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer

Includes: Supplementary data

Journal Articles

CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance

Donal J. Brennan, Karin Jirstrom, Åsa Kronblad, Robert C. Millikan, Goran Landberg, Michael J. Duffy, Lisa Rydén, William M. Gallagher, Sallyann L. O'Brien

Clin Cancer Res (2006) 12 (21): 6421–6431.

https://doi.org/10.1158/1078-0432.CCR-06-0480

Published: 03 November 2006

View article titled, CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance

Includes: Supplementary data

NARROW

Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution

BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer

A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk

High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy–Treated Patients—Results from a Population-Based Breast Cancer Cohort

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort

Abstract A37: Ectopic claudin 6 and 18.2 expression as potential treatment target in non-small cell lung cancer.

G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients

Abstract A9: The cocaine and amphetamine-regulated transcript (CART) is an independent prognostic factor in lymph node-negative breast cancer and predicts outcome in tamoxifen treated patients

Abstract A10: Peroxiredoxin-1 and oxidative stress: Controlling the balance between oncogenic and endocrine signalling in estrogen receptor-positive breast cancer

miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer

Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer

CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only